Chronic hepatitis B virus infection: issues in treatment.
As research continues to define the optimal management of chronic hepatitis B virus (HBV) infection, clinicians must deal with a number of yet unresolved issues: Should we treat all patients with HBV infection to prevent liver cancer, even if they have no evidence of active disease? Which is the best treatment strategy? What do we do with patients who develop resistance to our current drugs? Should we treat patients with HBV infection who have already developed cirrhosis?
O'Shea
Robert
R
Department of Gastroenterology and Hepatology, Cleveland Clinic Foundation, OH 44195, USA. oshear@ccf.org
D000998:Antiviral Agents / Q000627:therapeutic use; D002908:Chronic Disease; D006509:Hepatitis B / Q000150:complications / Q000628:therapy* / Q000821:virology; D006526:Hepatitis C; D006801:Humans; D008113:Liver Neoplasms / Q000209:etiology; D012307:Risk Factors
D000998:Antiviral Agents